Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-29

FDA Approved: PRUCALOPRIDE — Supplemental Application (Viona Pharmaceuticals Inc)

View source ↗

Summary

FDA approved a supplemental application for PRUCALOPRIDE submitted by Viona Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRUCALOPRIDE (Prucalopride)

Snippet

SUPPL AP for PRUCALOPRIDE (PRUCALOPRIDE)